Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology, Application (Cardiac, Troponin, BNP) – Global Forecast to 2025

  • Report ID:MRHC - 104334
  • Pages: 207
  • Sep 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Market Drivers
                    4.2.1.1. Venture Capital Funding for the Development of LOC-Based POC Diagnostics
                    4.2.1.2. Rising Prevalence of Chronic Diseases Coupled with Aging Population
                    4.2.1.3. Greater Benefits offered by Microfluidic/LOC Over Conventional Quantifiable Technologies
                    4.2.1.4. Rapid Decision Making in Emergency Care
                    4.2.1.5. Growing Need of POC Testing in Low-Resource Setting
                    4.2.1.6. Rising Research Activities Related to Microfluidic Technology
           4.2.2. Market Restraints
                    4.2.2.1. Tedious Regulatory Approval Process
                    4.2.2.2. Reluctance of Healthcare Professionals to Replace the Existing Diagnostic Platforms
           4.2.3. Market Opportunities
                    4.2.3.1. Significant Opportunities from Emerging Economies
                    4.2.3.2. Emerging Technologies Such as Paper-Based Microfluidics - offers New Growth Avenues
           4.2.4. Market Challenges
                    4.2.4.1. Selection of Suitable Substrate Material for Designing Microfluidic Chip
                    4.2.4.2. Product-Design and Cost Related Challenges in the Developing Countries
    4.3. Supply Chain Analysis
    4.4. Market Share Analysis
    4.5. Regulatory Analysis
           4.5.1. North America
           4.5.2. Europe
           4.5.3. Asia-Pacific
           4.5.4. Latin America, Middle East & Africa
    4.6. Pricing Analysis
           4.6.1. Cost Comparison: POC Tests Vs Central Lab Test
           4.6.2. Pricing Trend for Microfluidic Tests
           4.6.3. Single Analyte Testing Vs Multiple Analyte Testing (Panel Testing) in Microfluidic Detection

5. Quantitative POC Immunoassay Diagnostics Market, by Product Type
    5.1. Introduction
    5.2. Lab-On-Chip/Microfluidic Diagnostics
           5.2.1. Microfluidic Analyzers
           5.2.2. Microfluidic Cartridges
    5.3. Other Quantifiable Point of Care Diagnostics
           5.3.1. POC Analyzers
           5.3.2. Reagents and Assays

6. Quantitative Point of Care Clinical Immunoassay Diagnostics Market, by Technology ($Value)
    6.1. Introduction
    6.2. Point-of-Care Lab-On-Chip Technology
           6.2.1. Electrochemical LOC POC Technology
           6.2.2. Optical Point-of-Care Lab-On-Chip Technology
    6.3. Quantitative Non-LOC POC Technology

7. Microfluidic POC Immunoassay Diagnostics Market, by Application ($Value)
    7.1. Introduction
    7.2. Cardiac Biomarker Detection
           7.2.1. Single Biomarker Assay
                    7.2.1.1. Troponin
                    7.2.1.2. Brain Natriuretic Peptide (BNP)
                    7.2.1.3. Other Cardiac Biomarkers
           7.2.2. Multiplexed (Panel) Assay
    7.3. Inflammatory Biomarker Detection
    7.4. Other Biomarkers
    7.5. Emerging Biomarkers

8. Geographic Analysis
    8.1. Introduction
    8.2. North America
           8.2.1. U.S.
           8.2.2. Canada
    8.3. Europe
           8.3.1. Germany
           8.3.2. France
           8.3.3. U.K.
           8.3.4. Italy
           8.3.5. Spain
           8.3.6. Rest of Europe (RoE)
    8.4. Asia-Pacific (APAC)
           8.4.1. Japan
           8.4.2. China
           8.4.3. India
           8.4.4. Rest of Asia Pacific (RoAPAC)
    8.5. Rest of the World (RoW)
           8.5.1. Latin America (LATAM)
           8.5.2. Middle East and Africa

9. Competitive Landscape
    9.1. Competitive Benchmarking
    9.2. Quantitative POC Immunoassay Diagnostics Products

10. Company Profiles
    10.1. Abaxis, Inc. (A Subsidiary of Zoetis Inc.)
           10.1.1. Business Overview
           10.1.2. Financial Overview
           10.1.3. Product Portfolio
           10.1.4. Strategic Developments
    10.2. Nanomix, Inc.
           10.2.1. Business Overview
           10.2.2. Financial Overview
           10.2.3. Product Portfolio
           10.2.4. Strategic Developments
    10.3. Abbott Laboratories (Including Alere)
           10.3.1. Business Overview
           10.3.2. Financial Overview
           10.3.3. Product Portfolio
           10.3.4. Strategic Developments
    10.4. Koninklijke Philips N.V.
           10.4.1. Business Overview
           10.4.2. Financial Overview
           10.4.3. Product Portfolio
           10.4.4. Strategic Developments
    10.5. Biosurfit Sa
           10.5.1. Business Overview
           10.5.2. Financial Overview
           10.5.3. Product Portfolio
           10.5.4. Strategic Developments
    10.6. Micropoint Bioscience, Inc.
           10.6.1. Business Overview
           10.6.2. Financial Overview
           10.6.3. Product Portfolio
           10.6.4. Strategic Developments
    10.7. Siloam Biosciences, Inc.
           10.7.1. Business Overview
           10.7.2. Financial Overview
           10.7.3. Product Portfolio
           10.7.4. Strategic Developments
    10.8. NanoEnTek Inc.
           10.8.1. Business Overview
           10.8.2. Financial Overview
           10.8.3. Product Portfolio
           10.8.4. Strategic Developments
    10.9. Opko Health, Inc.
           10.9.1. Business Overview
           10.9.2. Financial Overview
           10.9.3. Product Portfolio
           10.9.4. Strategic Developments
    10.10. Quidel Corporation
           10.10.1. Business Overview
           10.10.2  Financial Overview
           10.10.3. Product Portfolio
           10.10.4. Strategic Developments

11. Appendix
    11.1. Industry Speaks

List of Tables

Table 1 Global Quantitative POC Clinical Immunoassay Diagnostics Market Drivers: Impact Analysis
Table 2 Global Quantitative POC Clinical Immunoassay Diagnostics Market Restraints: Impact Analysis
Table 3 Raw Material Suppliers for LOC POC Devices
Table 4 Contract Manufacturing Organizations (CMO) for LOC POC Devices
Table 5 OEMS for LOC POC Devices
Table 6 End-Users for LOC POC Devices
Table 7 Policy/Guidelines/Standards for POCT Devices in Europe
Table 8 POC Regulations in Asia-Pacific
Table 9 POC Regulations in Rest of the World
Table 10 Cost Comparison: LOC POC Test Vs Central Lab Test
Table 11 Price Comparison: Single and Multiple Analyte Tests
Table 12 Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017-2025 ($Million)
Table 13 Global Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017-2025 ($Million)
Table 14 Global Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017-2025 (Thousand Units)
Table 15 Global Lab-On-Chip/ Microfluidic Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
Table 16 Examples of Microfluidic-Based Analyzers
Table 17 Global Microfluidic Analyzers Market Size, by Country/Region, 2017-2025 ($Million)
Table 18 Global Microfluidic Analyzers Market Size, by Country/Region, 2017-2025 (Thousand Units)
Table 19 Advantages and Limitations of Substrate Materials
Table 20 Examples of Commercially Available Microfluidic-Based Cartridges
Table 21 Global Cartridges Market Size, by Country/Region, 2017-2025 ($Million)
Table 22 Global Microfluidic Cartridges Market Size, by Country/Region, 2017-2025 (Thousand Units)
Table 23 Global Other Quantifiable Point of Care Diagnostics Market Size, by Type, 2017-2025 ($Million)
Table 24 Global Other Quantifiable Point of Care Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
Table 25 Examples of Commercially Available POC Analyzers
Table 26 Global Market Size for Other POC Analyzers, by Country/Region, 2017-2025 ($Million)
Table 27 Examples of Commercially Available Non-LOC POC Assays
Table 28 Global Reagents and Assays Market Size, by Country/Region, 2017-2025 ($Million)
Table 29 Quantitative Point of Care Immunoassay Diagnostics Market, by Technology, 2017-2025 ($Million)
Table 30 Detection Technologies Used in Commercial Microfluidic POC Devices
Table 31 Global LOC POC Technology Market Size, by Type, 2017-2025 ($Million)
Table 32 Global LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 33 Global Electrochemical LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 34 OPTO-Microfluidic Detection Methods
Table 35 Global Optical LOC POC Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 36 Technologies Used in Commercial Quantitative Non-LOC POC Devices
Table 37 Global Non-LOC Point of Care Technology Market Size, by Country/Region, 2017-2025 ($Million)
Table 38 Global Quantitative POC Immunoassay Diagnostics Market Size, by Application, 2017-2025 ($Million)
Table 39 Global Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 40 Global Microfluidic POC Market Size for Cardiac Biomarkers, by Country/Region, 2017-2025 ($Million)
Table 41 Commercially Available Tests for Single Cardiac Biomarker Detection
Table 42 Global Microfluidic POC Market Size for Single Biomarker Assay, by Type, 2017-2025 ($Million)
Table 43 Global Microfluidic POC Market Size for Single Cardiac Biomarker Assay, by Country/Region, 2017-2025 ($Million)
Table 44 Global Microfluidic POC Market Size for Troponin Assay, by Country/Region, 2017 – 2025 ($Million)
Table 45 Global Microfluidic POC Market Size for BNP Assays, by Country/Region, 2017 – 2025 ($Million)
Table 46 Global Microfluidic POC Market Size for Other Cardiac Biomarkers, by Country/Region, 2017 – 2025 ($Thousand)
Table 47 Commercially Available Tests for Multiplexed Cardiac Assays
Table 48 Global Microfluidic POC Market Size for Multiplexed Cardiac Assay, by Country/Region, 2017-2025 ($Million)
Table 49 Global Microfluidic POC Market Size for inflammatory Biomarkers, by Country/Region, 2017-2025 ($Million)
Table 50 Tests/Devices for Hba1c and Glucose Detection
Table 51 Clinically Significant Tumor Markers
Table 52 Global LOC POC Immunodiagnostics Market Size for Other Biomarkers, by Country/Region, 2017-2025 ($Thousand)
Table 53 Emerging Biomarkers
Table 54 Global POC Immunoassay Diagnostics Market Size, by Country/Region, 2017-2025 ($Million)
Table 55 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017 – 2025 ($Million)
Table 56 North America: Microfluidic POC Immunoassay Diagnostics Market, by Country, 2017 – 2025 ($Million)
Table 57 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 58 North America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 59 North America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 60 North America: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 61 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 62 North America: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 63 North America: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 64 North America: Microfluidic POC Market size for Cardiac Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 65 North America: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 66 U.S.: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 67 U.S.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 68 U.S.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 69 U.S.: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 70 U.S.: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 71 U.S.: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 72 U.S.: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 73 U.S.: Microfluidic POC Market size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 74 U.S.: Microfluidic POC Market Size for Single Cardiac Biomarker, by Type, 2017 – 2025 ($Million)
Table 75 Canada: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 76 Canada: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 77 Canada: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 78 Canada: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 79 Canada: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 80 Canada: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 81 Canada: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 82 Canada: Microfluidic POC Market Size for Cardiac Biomarkers, by Type, 2017 – 2025 ($Million)
Table 83 Canada: Microfluidic POC Market Size for Single Biomarker, by Type, 2017 – 2025 ($Million)
Table 84 Europe: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017-2025 ($Million)
Table 85 Europe: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2017 – 2025 ($Million)
Table 86 Europe: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 87 Europe: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 88 Europe: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 89 Europe: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 90 Europe:  Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 91 Europe: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 92 Europe: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 93 Europe: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 94 Europe: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 95 Germany: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 96 Germany: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 97 Germany: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 98 Germany: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 99 Germany: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 100 Germany: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 101 Germany: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 102 Germany: Microfluidic POC Market Size for Cardiac Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 103 Germany: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 104 France: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 105 France: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 106 France: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 107 France: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 108 France: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 109 France: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 110 France: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 111 France: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 112 France: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 113 U.K.: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 114 U.K.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 115 U.K.: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 116 U.K.: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 117 U.K.: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 118 U.K.: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 119 U.K.: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 120 U.K.: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 121 U.K.: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 122 Italy: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 123 Italy: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 124 Italy: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 125 Italy: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 126 Italy: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 127 Italy: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Thousand)
Table 128 Italy: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 129 Italy: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 130 Italy: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 131 Spain: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 132 Spain: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 133 Spain: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 134 Spain: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 135 Spain: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 136 Spain: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 137 Spain: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 138 Spain: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 139 Spain: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 140 RoE: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 141 RoE: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 142 RoE: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 143 RoE: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 144 RoE: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 145 RoE: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 146 RoE: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 147 RoE: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 148 RoE: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 149 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2017-2025 ($Million)
Table 150 APAC: Microfluidic POC Immunoassay Diagnostics Market, by Country, 2017 – 2025 ($Million)
Table 151 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 152 APAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 153 APAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 154 APAC: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 155 APAC: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 156 APAC: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 157 APAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 158 APAC: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 159 APAC: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 160 Japan: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 161 Japan: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 162 Japan: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 163 Japan: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 164 Japan: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 165 Japan: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 166 Japan: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 167 Japan: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 168 Japan: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 169 China: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 170 China: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 171 China: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 172 China: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 173 China: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 174 China: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 175 China: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 176 China: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 177 China: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 178 India: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 179 India: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 180 India: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 181 India: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 182 India: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 183 India: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 184 India: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 185 India: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 186 India: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 187 RoAPAC: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 188 RoAPAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 189 RoAPAC: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 190 RoAPAC: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 191 RoAPAC: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 192 RoAPAC: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 193 RoAPAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 194 RoAPAC: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 195 RoAPAC: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 196 RoW: Quantitative POC Immunoassay Diagnostics Market, by Region, 2017-2025 ($Million)
Table 197 RoW: Microfluidic POC Immunoassay Diagnostics Market, by Region, 2017 – 2025 ($Million)
Table 198 RoW: Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 199 RoW: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 200 RoW: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 201 RoW: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 202 RoW: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 203 RoW: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 204 RoW: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 205 RoW: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 206 RoW: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 207 Latin America: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 208 Latin America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 209 Latin America: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 210 Latin America: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 211 Latin America: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 212 Latin America: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Million)
Table 213 Latin America: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Million)
Table 214 Latin America: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 215 Latin America: Microfluidic POC Market Size for Single Biomarkers, by Type, 2017 – 2025 ($Million)
Table 216 Middle East & Africa: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Product Type, 2017 – 2025 ($Million)
Table 217 Middle East & Africa: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 218 Middle East & Africa: Lab-On-Chip/Microfluidic Diagnostics Market Size, by Type, 2017 – 2025 (Thousand Units)
Table 219 Middle East & Africa: Other Quantifiable POC Diagnostics Market Size, by Type, 2017 – 2025 ($Million)
Table 220 Middle East & Africa: Quantitative POC Immunoassay Diagnostics Market Size, by Technology, 2017 – 2025 ($Million)
Table 221 Middle East & Africa: Microfluidic POC Technologies Market Size, by Type, 2017 – 2025 ($Thousand)
Table 222 Middle East & Africa: Microfluidic POC Immunoassay Diagnostics Market Size, by Application, 2017 – 2025 ($Thousand)
Table 223 Middle East & Africa: Microfluidic POC Market Size for Cardiac Biomarkers, by Assay Type, 2017 – 2025 ($Million)
Table 224 Middle East & Africa: Microfluidic POC Market Size for Single Biomarker Detection, by Type, 2017 – 2025 ($Million)
Table 225 Number of Developments by the Major Players During 2016-2019
Table 226 Quantitative POC Immunoassay Diagnostics: Competitive Benchmarking
Table 227 Key Products: Quantitative POC Immunoassay Diagnostics

List of Figures

Figure 1 Research Process
Figure 2 Key Executives interviewed
Figure 3 Market Size Estimation of LOC POC Immunodiagnostics Market
Figure 4 Market Size Estimation of Other Quantifiable POC Immunodiagnostics Market
Figure 5 Market Size Estimation of Total POC Immunoassay Market
Figure 6 Key Opportunities
Figure 7 Key Adopters of Microfluidic POC Clinical Immunoassay Diagnostics
Figure 8 LOC POC Technology Will Grow Fastest and Surpass Other Quantifiable POC Immunoassay Diagnostics Market by 2025
Figure 9 Quantitative POC Immunoassay Diagnostics Market Overview: 2019-2025
Figure 10 Global LOC POC Immunoassay Diagnostics Market, by Geography, 2018
Figure 11 Number of Cancer Cases Across the World (In Millions)
Figure 12 Prevalence of Diabetes, by Region, 2003 & 2025
Figure 13 Number of Deaths Attributed to Cardiovascular Diseases (Global), 2013-2030 (In Millions)
Figure 14 Disposable Personal income in China (In USD)
Figure 15 Supply Chain Analysis for LOC POC Immunoassay Diagnostics Market
Figure 16 Global Microfluidic POC Immunoassay Diagnostic Market Share, by Key Players, 2018
Figure 17 Pricing Trend for LOC-Based Diagnostic Test for the U.S. and China: 2017-2025
Figure 18 Quantitative POC Immunoassay Diagnostics Market Size, by Product Type, 2019-2025 ($Million)
Figure 19 Quantitative Point of Care Clinical Immunoassay Diagnostics Market, by Technology, 2019-2025 ($Million)
Figure 20 Global Quantitative POC Immunoassay Diagnostics Market Size, by Application, 2019-2025 ($Million)
Figure 21 Global POC Immunoassay Diagnostics Market Size, by Region, 2019-2025 ($Million)
Figure 22 North America: Quantitative POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 23 North America: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 24 Europe: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 25 Europe: Microfluidic POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 26 Percentage of Older People (65 Years and Above) in the France, 2000-2050
Figure 27 U.K.: Proportional Mortality, by Disease Type, 2014
Figure 28 Proportion of Elderly Population in Poland, 2000-2030 (%)
Figure 29 APAC: Quantitative POC Clinical Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 30 APAC: Microfluidic POC Immunoassay Diagnostics Market Size, by Country, 2019-2025 ($Million)
Figure 31 Japan: Proportional Mortality, 2014
Figure 32 China Population Growth Chart, 2010-2040
Figure 33 RoW: Quantitative POC Immunoassay Diagnostics Market, by Region, 2019-2025 ($Million)
Figure 34 RoW: Microfluidic POC Immunoassay Diagnostics Market, by Region, 2019-2025 ($Million)
Figure 35 Latin America: Aging Population, 2005-2050
Figure 36 Growth Strategies Adopted by Key Players
Figure 37 Zoetis Inc.: Financial Overview (2016-2018)
Figure 38 Abbott Laboratories: Financial Overview (2016-2018)
Figure 39 Koninklijke Philips N.V.: Financial Overview (2016-2018)
Figure 40 NanoEnTek, Inc: Financial Overview (2015-2017)
Figure 41 Opko Health, Inc.: Financial Overview (2016-2018)
Figure 42 Quidel Corporation: Financial Overview (2016-2018)

The Global Microfluidic Immunoassay Market is expected to grow at a CAGR of 12.7% from 2019 to reach $2.01 billion by 2025. Microfluidic immunoassay is rapidly growing industry with potential of improving patient health in low-resource settings. POC tests are performed in critical-care settings, ambulatory centers, physician office laboratories, or at patient’s home. The POC industry is growing at a faster pace due to demographic shift and need for high throughput diagnosis in cost effective manner. However, many of the present POC devices need sample pre-treatment before conducting the test, produce variable results, and offer either qualitative, semi-quantitative or poor quantitative test results. This led to rising focus on achieving precise and quantitative results; and miniaturization of POC devices. Microfluidic systems (lab-on-a-chip) have attracted a great deal of attention as a miniaturized immunodiagnostic platform. Major advantages of LOC include consumption of small volumes of reagents and sample; and delivery of precise results with fast turnaround time.

Rapid decision making in emergency care bolstering the growth of microfluidic immunoassay market

Microfluidic-based diagnosis has greater importance in cases of acute disease conditions. In the acute care settings -which are usually time-sensitive (for instance, cardiac care) - making rapid clinical decisions is of paramount importance. ECG is the primary diagnostic tool for patients presenting at the emergency department with chest pain. It enables identification of ST-elevation myocardial infarction (STEMI) to prioritize patient for the catheterization laboratory. However, for many patients suspected of acute coronary syndrome (ACS), there is no consistent ST-elevation. For this reason, blood testing for elevated levels of the cardiac markers is often performed simultaneously. However, it could take up to 60 minutes for results to come from the central laboratory which leads to delay in decision making. In such cases, microfluidic-based LOC tests can present quantitative results in less than 10 minutes and expedite the process of diagnosis and treatment. Owing to these factors, microfluidic-based tests are likely to witness more penetration in emergency departments of the healthcare settings in the coming years.

Emerging technologies such as paper based microfluidics offer significant opportunities

Microfluidic technology has gained significant interest in the recent years. This is mainly due to reduction in the requirement of cumbersome instruments by integrating whole laboratory procedure on a single chip. LOC technology is the result of nearly 2 decades of development and materials have been used in the designing of the devices. Paper material is gaining a lot of traction as a material for manufacturing microfluidics-based POC cartridges for third world countries. This is attributed to several advantages of paper material such as - it is an extremely cheap substrate material; compatible with many medical applications; and transports fluid through capillary forces without needing any external forces. Presently, a lot of research work in the field of paper-based microfluidics is on-going in the industry and academia. Diagnostics for All (DFA), Inc. (U.S.) is an example of one such organization involved in the development of low-cost paper-based LOC. The DFA was founded in 2007 by a group of scientists and entrepreneurs with an aim of developing low-cost diagnostics for cost-sensitive regions. In the past 10 years, the organization has received several funding for their ongoing research. If successfully developed and commercialized, paper-based microfluidics has potential to replace many conventional diagnostic devices.

Key Findings in the Global Microfluidic Immunoassay Market Study:

The microfluidic cartridges segment is estimated to command the largest share in 2019

The cartridge/microfluidic chip/disc/cassette is a core component of microfluidic system which integrates biosensor array, reagent storage, and fluid-handling components (FHCs). Microfilters, microchannels, microarrays, micropumps, microvalves, and microelectronics are the major sub-components - integrated onto chip to analyze and control biological constituents at the microscale. The cartridges are inserted into microfluidic analyzer or reader to detect the quantity of an analyte. The cartridges offered by the companies are either for single analyte testing or multiple analyte testing. Its cost depends on the method of design, type of material, and reagents used. Trend towards using microfluidic cartridges over conventional diagnostic strips (such as lateral flow strips) is expected to increase owing to its advantages such as rapid turnaround times (TAT) for test results, small reagents and sample volumes requirements, and better quantitative analysis.

Optical Detection segment to witness the highest demand through 2025

It is expected that by 2025, market share of optical detection will surpass the market share of electrochemical detection. This is mainly due to the on-going efforts to miniaturize the optical detection technology, greater sensitivity, its better suitability for conducting multiplexed assays, and focus of market players on launching optical detection-based products.

Asia-Pacific: The Fastest growing regional market for microfluidic immunoassay

North America commanded the largest share of the global microfluidic immunoassay market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, primarily due to accelerated growth of economies; improving healthcare infrastructure; rising accessibility to healthcare services & innovative products; increasing incidence of infectious and non-communicable diseases with aging population; growing disposable income; and continuous investment & focus of key players in emerging Asian markets.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global microfluidic immunoassay market are Abaxis, Inc. (a subsidiary of Zoetis Inc.), Nanōmix, Inc., Abbott Laboratories, Koninklijke Philips N.V., Biosurfit SA, Micropoint Bioscience, Inc., Siloam Biosciences, NanoEnTek Inc., OPKO Health, Inc., and Quidel Corporation among others.

Scope of the Report:

Market by Product Type

  • Lab-on-chip/microfluidic diagnostics
    • Microfluidic Analyzers
    • MicrofluidicCartridges
  • Other Quantifiable POC diagnostics
    • POC Analyzers
    • Reagents and Assays

 Market by Technology

  • Point of Care Lab on Chip Technology
    • Electrochemical LOC POC Technology
    • Optical POC LOC Technology
  • Non Lab on Chip Point of Care Technology

 Market by Application

  • Cardiac Biomarker Detection
    • Single Biomarker Assay
      • Troponin
      • Brain Natriuretic Peptide (BNP)
      • Other Cardiac Biomarkers
    • Multiplexed Panel Assay
  • Inflammatory Biomarker Detection
  • Other Biomarkers
  • Emerging Biomarkers

 Market by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report-

Advantages of LOC/microfluidics diagnostics over other quantifiable POC diagnostics will propel the microfluidic immunoassay market

  • How does the LOC/microfluidics diagnostics increase the efficiency and adoption of quantitative POC immunoassay diagnostics?
  • How are the leading players utilizing the advantages of LOC/microfluidics diagnostics in their products?

Cardiac Biomarker accounted for the largest share of the microfluidic immunoassay market

  • What factors are contributing to the frequent usage of cardiac biomarkers in various end users?
  • How does the adoption of cardiac biomarker differ from other application?

Asia-Pacific microfluidic immunoassay market favors both larger and local manufacturers that compete in multiple segments

  • What are the top competitors in this market and what strategies do they employ to gain shares?
  • What factors are driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market use to compete effectively?
  • What are the major drivers, restraints, challenges, and opportunities, in the global microfluidic immunoassay market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/countries?
Report Name
Full Name
Email
Job Title
Company
Country
Phone Number
--
Your Specific Interest
Captcha
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Connected Health / Digital Health Healthcare Analytics Medical Technologies
Download Free Sample
+91-744-778-0008